Abstract
Long-term androgen suppression (AS) with external beam radiation therapy (EBRT) may be one of the most effective treatments for patients with locally advanced prostate cancer. Alternatively, long-term AS may make bone mineral density (BMD), fat metabolism, anemia and other physiological factors get worse. We are now working on randomized controlled trial (RCT) comparing adjuvant IAS vs. continuous AS (CAS) following 14-month of AS and EBRT for patients with locally advanced prostate cancer (Prostate 63: 56, 2005).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
